Le Lézard
Classified in: Health
Subjects: CHI, PDT, DEI

InventHelp Inventors Develop New Fever Pops for Children (AJD-203)


PITTSBURGH, Feb. 14, 2024 /PRNewswire/ -- "I work at a children's hospital and thought there could be a way to administer necessary medications to a young child by taking advantage of their natural affinity for sweet treats," said one of two inventors, from Fairburn, Ga., "so we invented the FEVER POPS. Our flavorful design would help reduce fever and pain while also providing added hydration."

The patent-pending invention provides a new way to administer ibuprofen or acetaminophen to children. In doing so, it enhances convenience, flavor and fun. As a result, it enables the correct dosage to be administered without a fuss. It also offers the added benefit of cooling and hydrating young patients with fevers. The invention features a unique design that is easy to consume so it is ideal for parents with young children, hospitals, etc. Additionally, it is producible in design variations.

The original design was submitted to the Atlanta sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 22-AJD-203, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 04:19
Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that an abstract for the combination of fostroxacitabine bralpamide (fostrox) + Lenvima® in...

at 04:15
Asimov Achieves 10x Improvement in Lentiviral Production, Launches New Stable Cell Line Development Service
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the expansion of its LV Edge System with the launch of a fully stable cell line development service. There are now two ways for customers to...

at 04:07
Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients
Huma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of their innovative bladder cancer treatment companion app in...

at 04:00
Calibre Scientific Acquires Camlab Limited, a UK Provider of Scientific Equipment, Chemicals, Consumables and Other Laboratory Supplies
Calibre Scientific is pleased to announce the acquisition of Camlab Limited ("Camlab" or the "Company"), a UK-based supplier of scientific equipment, chemicals, consumables, labware, and other laboratory supplies and services to customers in the...

at 04:00
Hurom Takes Global Action to Protect Juicer Patents
Hurom, a pioneer in the development of the slow juicer and a leader in the global market, is stepping up efforts to safeguard patent rights worldwide to protect its proprietary technology and contribute to a healthy industry ecosystem. Despite...

at 03:46
Biosimilar Testing and Development Services Market to Hold $7.8 Billion, by 2032 with 12.1% CAGR: Allied Market Research
Allied Market Research published a report titled, "Biosimilar Testing and Development Services Market Share, Size, Competitive Landscape and Trend Analysis Report by Type, by End User: Global Opportunity Analysis and...

More news about Health...


News published on and distributed by: